BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23030357)

  • 1. Comparison of the effects of a new 32-gauge × 4-mm pen needle and a 32-gauge × 6-mm pen needle on glycemic control, safety, and patient ratings in Japanese adults with diabetes.
    Miwa T; Itoh R; Kobayashi T; Tanabe T; Shikuma J; Takahashi T; Odawara M
    Diabetes Technol Ther; 2012 Dec; 14(12):1084-90. PubMed ID: 23030357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes.
    Hirsch LJ; Gibney MA; Albanese J; Qu S; Kassler-Taub K; Klaff LJ; Bailey TS
    Curr Med Res Opin; 2010 Jun; 26(6):1531-41. PubMed ID: 20429832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge x 6 mm needle versus a 29 gauge x 12.7 mm needle in obese patients with diabetes mellitus.
    Schwartz S; Hassman D; Shelmet J; Sievers R; Weinstein R; Liang J; Lyness W
    Clin Ther; 2004 Oct; 26(10):1663-78. PubMed ID: 15598483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes.
    Hirsch L; Gibney M; Berube J; Manocchio J
    J Diabetes Sci Technol; 2012 Mar; 6(2):328-35. PubMed ID: 22538142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes.
    Bergenstal RM; Strock ES; Peremislov D; Gibney MA; Parvu V; Hirsch LJ
    Mayo Clin Proc; 2015 Mar; 90(3):329-38. PubMed ID: 25662503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. User experiences with second-generation 32-gauge × 4 mm vs. thinner comparator pen needles: prospective randomized trial.
    Gibney MA; Fitz-Patrick D; Klonoff DC; Whooley S; Lu B; Yue W; Glezer S
    Curr Med Res Opin; 2020 Oct; 36(10):1591-1600. PubMed ID: 32723109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes.
    McKay M; Compion G; Lytzen L
    Diabetes Technol Ther; 2009 Mar; 11(3):195-201. PubMed ID: 19267582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6mm and Micro Fine Plus 31-gauge 5mm needles.
    Iwanaga M; Kamoi K
    Diabetes Technol Ther; 2009 Feb; 11(2):81-6. PubMed ID: 19848573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study Protocol for a Prospective, Multicenter, Randomized, Open-Label, Parallel-Group Clinical Trial Comparing the Efficacy and Safety of a Needle-Free Insulin Injector and a Conventional Insulin Pen in Controlling Blood Glucose Concentrations in Chinese Patients with Type 2 Diabetes Mellitus (The FREE Study).
    Ji L; Chen L; Wang Y; Ma Z; Ran X; Sun Z; Xu X; Wang G; Guo L; Shan Z
    Adv Ther; 2019 Jun; 36(6):1485-1496. PubMed ID: 31004325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between shorter straight and thinner microtapered insulin injection needles.
    Nagai Y; Ohshige T; Arai K; Kobayashi H; Sada Y; Ohmori S; Furukawa K; Kato H; Kawata T; Ohta A; Tanaka Y
    Diabetes Technol Ther; 2013 Jul; 15(7):550-5. PubMed ID: 23621793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pen needle preference in a population of Canadians with diabetes: results from a recent patient survey.
    Berard L; Cameron B; Woo V
    Can J Diabetes; 2015 Jun; 39(3):206-9. PubMed ID: 25732758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: "thin-wall" needles compared to "regular-wall" needles: an open-label study.
    Siegmund T; Blankenfeld H; Schumm-Draeger PM
    Diabetes Technol Ther; 2009 Aug; 11(8):523-8. PubMed ID: 19698066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preference for a new prefilled insulin pen compared with the original pen.
    Garg S; Bailey T; DeLuzio T; Pollom D
    Curr Med Res Opin; 2011 Dec; 27(12):2323-33. PubMed ID: 21988614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes.
    Kreugel G; Keers JC; Kerstens MN; Wolffenbuttel BH
    Diabetes Technol Ther; 2011 Jul; 13(7):737-41. PubMed ID: 21476936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a crossover randomized non-inferiority trial; AGO 02 study.
    De Berardis G; Scardapane M; Lucisano G; Abbruzzese S; Bossi AC; Cipponeri E; D'Angelo P; Fontana L; Lancione R; Marelli G; Sciangula L; Nicolucci A
    Curr Med Res Opin; 2018 Sep; 34(9):1699-1704. PubMed ID: 29924641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of injection technique in use of insulin pens: prospective evaluation of a 31-gauge, 8-mm insulin pen needle.
    Jamal R; Ross SA; Parkes JL; Pardo S; Ginsberg BH
    Endocr Pract; 1999; 5(5):245-50. PubMed ID: 15251661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycemic control, reported pain and leakage with a 4 mm × 32 G pen needle in obese and non-obese adults with diabetes: a post hoc analysis.
    Hirsch LJ; Gibney MA; Li L; Bérubé J
    Curr Med Res Opin; 2012 Aug; 28(8):1305-11. PubMed ID: 22762347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized, multinational, open-label, 2-period, crossover comparison of biphasic insulin aspart 30 and biphasic insulin lispro 25 and pen devices in adult patients with type 2 diabetes mellitus.
    Niskanen L; Jensen LE; Råstam J; Nygaard-Pedersen L; Erichsen K; Vora JP
    Clin Ther; 2004 Apr; 26(4):531-40. PubMed ID: 15189750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety and acceptability of the new pen needle 33G × 4 mm. AGO 01 study.
    Valentini M; Scardapane M; Bondanini F; Bossi A; Colatrella A; Girelli A; Ciucci A; Leotta S; Minotti E; Pasotti F; Pesenti A; Rocca L; Sciangula L; Vavassori E; Nicolucci A
    Curr Med Res Opin; 2015 Mar; 31(3):487-92. PubMed ID: 25469829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.